Exelixis Financials - Benzinga

Exelixis Inc

EXELNASDAQ

Trade with Public

Trade with Public

$54.37

0.681.27%

Dern. MÀJ: Aug 21, 2:07 PM

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Actionnariat Comparer Options Rapport sur les stocks

Exelixis Financials

Exelixis (EXEL) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Exelixis Lowers FY2026 Sales Guidance from $2.525B-$2.625B to $2.500B-$2.550B vs $2.595B Est

Exelixis (NASDAQ:EXEL) lowers FY2026 sales outlook from $2.525 billion-$2.625 billion to $2.500 billion-$2.550 billion vs $2.595 billion estimate.

Benzinga Newsdesk

PRO
Exelixis Q2 Adj. EPS $0.91 Beats $0.79 Estimate, Sales $628.700M Miss $635.951M Estimate

Exelixis (NASDAQ:EXEL) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.79 by 15.19 percent. This is a 21.33 percent increase over earnings of $0.75 per share from the same

Benzinga Newsdesk

PRO
Exelixis Affirms FY2026 Sales Guidance of $2.525B-$2.625B vs $2.583B Est

Exelixis (NASDAQ:EXEL) affirms FY2026 sales outlook from $2.525 billion-$2.625 billion to $2.525 billion-$2.625 billion vs $2.583 billion estimate.

Benzinga Newsdesk

PRO
Exelixis Q1 Adj. EPS $0.87 Beats $0.70 Estimate, Sales $610.812M Beat $605.196M Estimate

Exelixis (NASDAQ:EXEL) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.70 by 24.29 percent. This is a 40.32 percent increase over earnings of $0.62 per share from the same

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

PRO
Exelixis Affirms FY2026 Sales Guidance of $2.525B-$2.625B

Exelixis (NASDAQ:EXEL) affirms FY2026 sales outlook from $2.525 billion-$2.625 billion to $2.525 billion-$2.625 billion.

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved